Interestingly, Myhre and colleagues confirmed in a prospective observational study that the GDF15 offers a prognostic biomarker superior to other inflammatory biomarkers in unselected hospitalized COVID-19 patients [68]. The gene discussed is GDF15; the disease is COVID-19.